(Q33630990)

English

Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system (English)

1 reference

Europe PubMed Central

28 July 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Tanaka E

1

1 reference

Europe PubMed Central

28 July 2017

Hisawa S

2

1 reference

Europe PubMed Central

28 July 2017

publication date

1 February 1999

1 reference

Europe PubMed Central

28 July 2017

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

28 July 2017

24

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

7-16

1 reference

Europe PubMed Central

28 July 2017

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Genetic polymorphism of S-mephenytoin hydroxylation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

The drug interaction potential of ranitidine: an update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Cytochromes P450 mediating the N-demethylation of amitriptyline

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Intestinal toxicity of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Interaction between carbamazepine and fluvoxamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Fluoxetine-warfarin interaction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Potential terfenadine-fluoxetine interaction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Probable terfenadine-fluoxetine-associated cardiac toxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Metabolic interaction between amitriptyline and perphenazine in psychiatric patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Interaction between amitriptyline and phenothiazine in man: Effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Carbamazepine-induced changes in plasma levels of neuroleptics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Interactions between antipsychotic and antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Increased trimipramine plasma levels during fluvoxamine comedication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00200.X

21 January 2018

Identifiers

10.1046/J.1365-2710.1999.00200.X

1 reference

Europe PubMed Central

28 July 2017

release_uz54un2y3fhmlivejusoejsxz4

1 reference

https://api.fatcat.wiki/v0/release/uz54un2y3fhmlivejusoejsxz4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33630990&oldid=2143276598"